tiprankstipranks
Trending News
More News >
Brenntag AG (DE:BNR)
XETRA:BNR
Advertisement

Brenntag AG (BNR) AI Stock Analysis

Compare
30 Followers

Top Page

DE:BNR

Brenntag AG

(XETRA:BNR)

Rating:66Neutral
Price Target:
€60.00
▲(18.67% Upside)
Brenntag AG's overall stock score is driven by its stable financial performance and attractive valuation. The strong balance sheet and cash flow generation are significant strengths. However, the negative revenue growth trend and mixed technical indicators present potential risks. The stock appears fairly valued with a reasonable dividend yield, making it a moderate investment opportunity.

Brenntag AG (BNR) vs. iShares MSCI Germany ETF (EWG)

Brenntag AG Business Overview & Revenue Model

Company DescriptionBrenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company operates through the divisions Brenntag Essentials and Brenntag Specialties. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including nutrition, pharma, personal care, water treatment, and lubricants; and home, industrial, and institutional markets, as well as coatings and constructions, polymers, and rubber industries. Brenntag SE was founded in 1874 and is based in Essen, Germany.
How the Company Makes MoneyBrenntag AG generates revenue primarily through the sale of chemicals to various industries, leveraging its extensive distribution network to serve a diverse customer base. The company's revenue model is based on a markup on the chemicals it purchases from manufacturers, which it then sells to customers. Key revenue streams include the distribution of bulk chemicals, specialty chemicals, and value-added services such as blending, repackaging, and logistics. Additionally, Brenntag benefits from long-term partnerships with major chemical producers, ensuring a steady supply of products and competitive pricing. The company's ability to provide customized solutions for specific sectors further enhances its revenue potential, as it allows for higher margins in specialized markets.

Brenntag AG Financial Statement Overview

Summary
Brenntag AG demonstrates stable financial performance with strong profitability and cash flow generation. The balance sheet is robust, featuring low leverage and solid equity returns. However, the negative revenue growth trend is a concern that could impact future performance.
Income Statement
68
Positive
Brenntag AG's income statement shows a mixed performance. The TTM (Trailing-Twelve-Months) data indicates a slight decline in revenue growth at -1.88%, which is a concern. However, the company maintains a stable gross profit margin of 22.08% and a net profit margin of 3.25%. The EBIT and EBITDA margins are moderate at 5.43% and 8.24%, respectively. Overall, while profitability metrics are stable, the negative revenue growth trend is a potential risk.
Balance Sheet
75
Positive
The balance sheet of Brenntag AG reflects a solid financial position with a low debt-to-equity ratio of 0.13 in the TTM period, indicating low leverage. The return on equity is healthy at 11.63%, suggesting efficient use of equity. The equity ratio stands at 39.02%, showing a strong equity base relative to total assets. The company's balance sheet is robust, with low leverage and good returns on equity.
Cash Flow
72
Positive
Brenntag AG's cash flow statement reveals a positive trajectory with a free cash flow growth rate of 2.75% in the TTM period. The operating cash flow to net income ratio is 2.15, indicating strong cash generation relative to net income. The free cash flow to net income ratio is 0.63, showing a good conversion of net income into free cash flow. Overall, the cash flow position is strong, with positive growth and good cash conversion metrics.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue16.00B16.24B16.82B19.43B14.38B11.78B
Gross Profit4.01B4.03B4.02B4.32B3.38B2.77B
EBITDA1.30B1.33B1.51B1.70B1.03B995.90M
Net Income423.00M536.20M714.90M886.80M448.30M466.50M
Balance Sheet
Total Assets10.79B11.67B10.34B11.37B10.20B8.14B
Cash, Cash Equivalents and Short-Term Investments531.70M763.30M576.90M1.05B705.00M726.30M
Total Debt551.90M3.38B2.40B2.93B2.66B2.02B
Total Liabilities6.55B6.91B5.98B6.57B6.20B4.53B
Stockholders Equity4.21B4.73B4.30B4.75B3.91B3.55B
Cash Flow
Free Cash Flow586.10M564.40M1.34B689.50M189.30M1.02B
Operating Cash Flow907.80M906.60M1.66B956.70M388.60M1.22B
Investing Cash Flow-523.00M-749.00M-558.30M-401.40M-608.50M-224.10M
Financing Cash Flow-495.00M23.00M-1.55B-225.80M174.10M-735.60M

Brenntag AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price50.56
Price Trends
50DMA
54.48
Negative
100DMA
56.36
Negative
200DMA
57.25
Negative
Market Momentum
MACD
-1.16
Positive
RSI
32.60
Neutral
STOCH
23.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:BNR, the sentiment is Negative. The current price of 50.56 is below the 20-day moving average (MA) of 52.78, below the 50-day MA of 54.48, and below the 200-day MA of 57.25, indicating a bearish trend. The MACD of -1.16 indicates Positive momentum. The RSI at 32.60 is Neutral, neither overbought nor oversold. The STOCH value of 23.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:BNR.

Brenntag AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
66
Neutral
€7.32B17.319.86%4.15%-1.30%-28.95%
61
Neutral
$10.48B7.52-0.05%2.87%2.87%-36.73%
€10.83B-5.90%
€7.46B17.604.87%
67
Neutral
€4.67B14.0916.29%3.69%2.35%-0.09%
$2.33B-3.72%0.81%
$3.64B14.295.37%3.77%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:BNR
Brenntag AG
50.56
-10.84
-17.66%
GB:0RBE
Covestro
58.84
3.05
5.47%
GB:0QDS
Evonik
15.99
-2.81
-14.95%
DE:FPE
Fuchs Petrolub
31.40
1.95
6.62%
LNXSF
LANXESS
27.09
-0.70
-2.52%
WKCMF
Wacker Chemie AG
74.07
-10.57
-12.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 20, 2025